Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Treatment of cognitive impairment of mucopolysaccharidosis type IIIA by intrathecal delivery of heparan N-sulfatase

Treatment of cognitive impairment of mucopolysaccharidosis type IIIA by intrathecal delivery of heparan N-sulfatase

US Patent 10639356 · Granted May 5, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-CCL2 and anti-LOXL2 combination therapy for treatment of scleroderma2021
Amyloid precursor protein (APP) RNAi agent compositions and methods of use there2021
Determination of glycosaminoglycan levels by mass spectrometry2020